Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 15, 2025Frontiers in Veterinary ScienceOpen Access

Towards precision pain management in veterinary practise: opportunities and barriers

View Full Paper
Ask AI
Bookmark
Share

Authors

JJJade-Lily C. JonovskiThe University of SydneyEBElouise K. BaconThe University of SydneyBVBrandon D. VelieThe University of Sydney

Discussion

Loading...

Member takes

Implication

Review highlights opportunities and barriers to implement pharmacogenetics in pain management for veterinary patients, suggesting significant improvements in treatment efficacy.

Key Points

  • Precision medicine seeks to improve therapeutic outcomes in veterinary practice by tailoring pain management strategies based on pharmacogenetic insights, enhancing patient welfare.
  • Current veterinary drug approaches primarily rely on standardised dosing based on population averages, neglecting individual genetic variances that influence response to pain management.
  • Assessments of pharmacogenetic traits, such as certain gene variants, can provide actionable insights for analgesic response, demonstrating the potential of personalised treatment in animals.
  • Despite the promise of precision analgesia, systemic barriers, including cost and access to genetic testing, hinder broader adoption in veterinary medicine.

Cite This Study

Jonovski et al. (2025) studied this question.

synapsesocial.com/papers/68af509bad7bf08b1ead886dhttps://doi.org/10.3389/fvets.2025.1658765
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia2004 · 97 citations
  2. 2Impact of Tetrahydropalmatine on the Pharmacokinetics of Probe Drugs for CYP1A2, 2D6 and 3A Isoenzymes in Beagle Dogs2016 · 10 citations
  3. 3Anesthetic Requirement Is Increased in Redheads2004 · 192 citations
  4. 4Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene2001 · 458 citations
  5. 5Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder2011 · 84 citations